CN103990093A - Traditional Chinese medicine for treating obstructive emphysema caused by spleen-deficiency and phlegm-turbid stagnation - Google Patents
Traditional Chinese medicine for treating obstructive emphysema caused by spleen-deficiency and phlegm-turbid stagnation Download PDFInfo
- Publication number
- CN103990093A CN103990093A CN201410225393.6A CN201410225393A CN103990093A CN 103990093 A CN103990093 A CN 103990093A CN 201410225393 A CN201410225393 A CN 201410225393A CN 103990093 A CN103990093 A CN 103990093A
- Authority
- CN
- China
- Prior art keywords
- parts
- grams
- chinese medicine
- rhizoma
- phlegm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine for treating obstructive emphysema caused by spleen-deficiency and phlegm-turbid stagnation. The traditional Chinese medicine is characterized by being prepared from the following medicinal materials in parts by weight: 50 parts of Chinese yam, 15 parts of gordon euryale, 12 parts of ginkgo, 15 parts of bighead atractylodes rhizome, 15 parts of poria cocos, 30 parts of astragalus membranaceus, 15 parts of fried perillaseeds, 15 parts of burdocks, 15 parts of fried semen raphani, 6 parts of ephedra, 12 parts of almonds, 12 parts of rhizoma pinellinae praeparata, 9 parts of pericarpium citri reticulatae, 15 parts of angelica sinensis, 15 parts of radix rehmanniae preparata, 9 parts of blackberry lilies, 6 parts of rhizoma zingiberis, 6 parts of schisandra chinensis, 12 parts of houttuynia cordata, 6 parts of agilawood, 12 parts of codonopsis pilosula and 6 parts of liquorice. Clinical experiments verify that the traditional Chinese medicine disclosed by the invention can safely and effectively treat obstructive emphysema caused by spleen-deficiency and phlegm-turbid stagnation.
Description
Technical field
The present invention relates to a kind of emophysematous Chinese medicine, particularly a kind of Chinese medicine for the treatment of the obstructive emphysema of insufficiency of the spleen phlegm-damp.
Background technology
Emphysema refer to that alveolar excessively inflates, expands, causes lung tissue elasticity attenuation, lung volume are increased, the chronic lung disease that pulmonary function lowers.By the reason of its formation, can be divided into clinically obstructive emphysema of chronic obstructive emphysema, compensatory emphysema, aging-lung emphysema, interstitial emphysema, insufficiency of the spleen phlegm-damp etc.Its sickness rate is higher, and often can cause the serious consequences such as pulmonary heart disease and respiratory failure.Main clinical manifestation is for cough, expectoration increases the weight of, and cyanosis, headache, the respiratory failure performance such as drowsiness appear in dyspnea.Obstructive emphysema for insufficiency of the spleen phlegm-damp still lacks the effective medicine of generally recognized as safe at present.
Summary of the invention
The problem to be solved in the present invention is: a kind of Chinese medicine for the treatment of the obstructive emphysema of insufficiency of the spleen phlegm-damp is provided, by selecting suitable medical material and proportioning thereof, reaches the object of the obstructive emphysema of the insufficiency of the spleen phlegm-damp of safe and effective healing.
In order to solve the problems of the technologies described above, the present invention by the following technical solutions:
A Chinese medicine for the treatment of the obstructive emphysema of insufficiency of the spleen phlegm-damp, is characterized in that, it is that medical material by following parts by weight proportioning is prepared into: 50 parts of Rhizoma Dioscoreaes, 15 parts of Semen Euryaless, 12 parts of Semen Ginkgoes, 15 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts, Poria, 30 parts of the Radixs Astragali, 15 parts of stir-baked FRUCTUS PERILLAEs, 15 parts of Fructus Arctiis, 15 parts of Semen Raphani (parched), 6 parts, Herba Ephedrae, 12 parts, Semen Armeniacae Amarum, 12 parts of Rhizoma Pinelliae Preparatum, 9 parts of Pericarpium Citri Reticulataes, 15 parts of Radix Angelicae Sinensis, 15 parts, Radix Rehmanniae Preparata, 9 parts of Rhizoma Belamcandae, 6 parts of Rhizoma Zingiberiss, 6 parts of Fructus Schisandrae Chinensis, 12 parts of Herba Houttuyniae, 6 parts of Lignum Aquilariae Resinatum, 12 parts of Radix Codonopsis, 6 parts, Radix Glycyrrhizae.
Below in conjunction with clinical experiment data declaration beneficial effect of the present invention:
1, general material
Inventor in June, 2008-2013 collects the out-patient of the obstructive emphysema of 80 routine insufficiency of the spleen phlegm-damp, age 48-76 year, course of disease 1-5 altogether between year August.Be divided at random: treatment group 50 examples, blank group 30 examples.The data there was no significant differences such as two groups of ages, the state of an illness, have comparability.
2, test method
The oral common antibiosis anti-inflammatory drug of matched group, is used to specifications.1 month course for the treatment of.
The capsule that the oral the present invention for the treatment of group makes according to specific embodiment 1, every bu is taken for 2 times sooner or later.1 month course for the treatment of.
3, criterion of therapeutical effect and therapeutic outcome
3.1 criterion of therapeutical effect
(1) recovery from illness: clinical symptoms and sign disappear completely or substantially disappear;
(2) effective: clinical symptoms and sign are most of to take a turn for the better or is clearly better;
(3) invalid; Clinical symptoms and sign are all not improved, and symptom is as front, DeGrain.
3.2 treatment statistical results are in Table 1.
Table 1 liang group curative effect comparison
| Group | Case number | Recovery from illness | Effective | Invalid | Untoward reaction | Total effective rate % |
| Treatment group | 50 | 10 | 34 | 6 | 0(0％) | 88％ |
| Matched group | 30 | 0 | 2 | 28 | 0(0％) | 7％ |
Visible, the medicine that the preferred embodiment for the present invention makes can be treated the obstructive emphysema of insufficiency of the spleen phlegm-damp safely and effectively.
The specific embodiment
In order to understand better and to implement the present invention, below in conjunction with specific embodiment, further illustrate the present invention.
Specific embodiment 1
Take 50 grams of Rhizoma Dioscoreaes, 15 grams of Semen Euryaless, 12 grams of Semen Ginkgoes, 15 grams of the Rhizoma Atractylodis Macrocephalaes, 15 grams, Poria, 30 grams of the Radixs Astragali, 15 grams of stir-baked FRUCTUS PERILLAEs, 15 grams of Fructus Arctiis, 15 grams of Semen Raphani (parched), 6 grams, Herba Ephedrae, 12 grams, Semen Armeniacae Amarum, 12 grams of Rhizoma Pinelliae Preparatum, 9 grams of Pericarpium Citri Reticulataes, 15 grams of Radix Angelicae Sinensis, 15 grams, Radix Rehmanniae Preparata, 9 grams of Rhizoma Belamcandae, 6 grams of Rhizoma Zingiberiss, 6 grams of Fructus Schisandrae Chinensis, 12 grams of Herba Houttuyniae, 6 grams of Lignum Aquilariae Resinatum, 12 grams of Radix Codonopsis, 6 grams, Radix Glycyrrhizae.Add 10 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 8 times of water gagings, decocts 1 hour, filters; Merging filtrate, concentrated, dry, pack in capsulae vacuus, must meet the capsule of one day consumption of normal adult.
The obstructive emphysema that is used for the treatment of insufficiency of the spleen phlegm-damp.Oral, every bu is taken for twice sooner or later.
Specific embodiment 2
Take 50 grams of Rhizoma Dioscoreaes, 15 grams of Semen Euryaless, 12 grams of Semen Ginkgoes, 15 grams of the Rhizoma Atractylodis Macrocephalaes, 15 grams, Poria, 30 grams of the Radixs Astragali, 15 grams of stir-baked FRUCTUS PERILLAEs, 15 grams of Fructus Arctiis, 15 grams of Semen Raphani (parched), 6 grams, Herba Ephedrae, 12 grams, Semen Armeniacae Amarum, 12 grams of Rhizoma Pinelliae Preparatum, 9 grams of Pericarpium Citri Reticulataes, 15 grams of Radix Angelicae Sinensis, 15 grams, Radix Rehmanniae Preparata, 9 grams of Rhizoma Belamcandae, 6 grams of Rhizoma Zingiberiss, 6 grams of Fructus Schisandrae Chinensis, 12 grams of Herba Houttuyniae, 6 grams of Lignum Aquilariae Resinatum, 12 grams of Radix Codonopsis, 6 grams, Radix Glycyrrhizae.Add 12 times of water gagings, decoct 2 hours, filter; Filtering residue adds 10 times of water gagings, decocts 1.5 hours, filters; Merging filtrate, concentrated, dry, pack, must meet the powder of one day consumption of normal adult.
The obstructive emphysema that is used for the treatment of insufficiency of the spleen phlegm-damp.Oral, every bu is taken for twice sooner or later.
Specific embodiment 3
Take 50 grams of Rhizoma Dioscoreaes, 15 grams of Semen Euryaless, 12 grams of Semen Ginkgoes, 15 grams of the Rhizoma Atractylodis Macrocephalaes, 15 grams, Poria, 30 grams of the Radixs Astragali, 15 grams of stir-baked FRUCTUS PERILLAEs, 15 grams of Fructus Arctiis, 15 grams of Semen Raphani (parched), 6 grams, Herba Ephedrae, 12 grams, Semen Armeniacae Amarum, 12 grams of Rhizoma Pinelliae Preparatum, 9 grams of Pericarpium Citri Reticulataes, 15 grams of Radix Angelicae Sinensis, 15 grams, Radix Rehmanniae Preparata, 9 grams of Rhizoma Belamcandae, 6 grams of Rhizoma Zingiberiss, 6 grams of Fructus Schisandrae Chinensis, 12 grams of Herba Houttuyniae, 6 grams of Lignum Aquilariae Resinatum, 12 grams of Radix Codonopsis, 6 grams, Radix Glycyrrhizae.Add 8 times of water gagings, decoct 2 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1.5 hours, filters; Merging filtrate, concentrated, dry, then add appropriate dextrin and correctives, and according to this area common process, granulate, pack, must meet the granule of one day consumption of normal adult.
The obstructive emphysema that is used for the treatment of insufficiency of the spleen phlegm-damp.Oral, every bu is taken for twice sooner or later.
Through a large amount of clinical treatments, facts have proved, the present invention treats the Chinese medicine of the obstructive emphysema of insufficiency of the spleen phlegm-damp, belong to pure Chinese medicinal preparation, little to human body toxicity, side effect, to treating the obstructive emphysema of insufficiency of the spleen phlegm-damp, have reliably, safety, significant therapeutic effect.
Claims (1)
1. a Chinese medicine for the treatment of the obstructive emphysema of insufficiency of the spleen phlegm-damp, is characterized in that, it is that medical material by following parts by weight proportioning is prepared into: 50 parts of Rhizoma Dioscoreaes, 15 parts of Semen Euryaless, 12 parts of Semen Ginkgoes, 15 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts, Poria, 30 parts of the Radixs Astragali, 15 parts of stir-baked FRUCTUS PERILLAEs, 15 parts of Fructus Arctiis, 15 parts of Semen Raphani (parched), 6 parts, Herba Ephedrae, 12 parts, Semen Armeniacae Amarum, 12 parts of Rhizoma Pinelliae Preparatum, 9 parts of Pericarpium Citri Reticulataes, 15 parts of Radix Angelicae Sinensis, 15 parts, Radix Rehmanniae Preparata, 9 parts of Rhizoma Belamcandae, 6 parts of Rhizoma Zingiberiss, 6 parts of Fructus Schisandrae Chinensis, 12 parts of Herba Houttuyniae, 6 parts of Lignum Aquilariae Resinatum, 12 parts of Radix Codonopsis, 6 parts, Radix Glycyrrhizae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410225393.6A CN103990093A (en) | 2014-05-26 | 2014-05-26 | Traditional Chinese medicine for treating obstructive emphysema caused by spleen-deficiency and phlegm-turbid stagnation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410225393.6A CN103990093A (en) | 2014-05-26 | 2014-05-26 | Traditional Chinese medicine for treating obstructive emphysema caused by spleen-deficiency and phlegm-turbid stagnation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103990093A true CN103990093A (en) | 2014-08-20 |
Family
ID=51304593
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410225393.6A Pending CN103990093A (en) | 2014-05-26 | 2014-05-26 | Traditional Chinese medicine for treating obstructive emphysema caused by spleen-deficiency and phlegm-turbid stagnation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103990093A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104524532A (en) * | 2015-01-14 | 2015-04-22 | 鲁卫章 | Traditional Chinese composition for treating qi deficiency and blood stasis phlegm-dampness stagnation type obstructive emphysema |
| CN104667012A (en) * | 2015-03-18 | 2015-06-03 | 王岷 | Medicine for treating phlegm clouding clear orifices obstructive emphysema and preparation method of medicine |
| CN104958532A (en) * | 2015-06-17 | 2015-10-07 | 济南正骐生物科技有限公司 | Traditional Chinese medicine for treating bronchitic obstructive emphysema and preparation method thereof |
| CN105079355A (en) * | 2015-09-23 | 2015-11-25 | 谢桂斌 | Medicine for treating senile emphysema |
| CN109045233A (en) * | 2018-09-30 | 2018-12-21 | 宁夏医科大学 | For treating Chinese medicine composition, preparation method and its application of Chronic Obstructive Pulmonary Disease |
-
2014
- 2014-05-26 CN CN201410225393.6A patent/CN103990093A/en active Pending
Non-Patent Citations (1)
| Title |
|---|
| 姜宁等主编: "《呼吸系统疾病诊治绝招》", 31 August 2008, 河北科学技术出版社 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104524532A (en) * | 2015-01-14 | 2015-04-22 | 鲁卫章 | Traditional Chinese composition for treating qi deficiency and blood stasis phlegm-dampness stagnation type obstructive emphysema |
| CN104667012A (en) * | 2015-03-18 | 2015-06-03 | 王岷 | Medicine for treating phlegm clouding clear orifices obstructive emphysema and preparation method of medicine |
| CN104958532A (en) * | 2015-06-17 | 2015-10-07 | 济南正骐生物科技有限公司 | Traditional Chinese medicine for treating bronchitic obstructive emphysema and preparation method thereof |
| CN105079355A (en) * | 2015-09-23 | 2015-11-25 | 谢桂斌 | Medicine for treating senile emphysema |
| CN109045233A (en) * | 2018-09-30 | 2018-12-21 | 宁夏医科大学 | For treating Chinese medicine composition, preparation method and its application of Chronic Obstructive Pulmonary Disease |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103977378A (en) | Traditional Chinese medicine for treating toxic bacillary dysentery | |
| CN103585299B (en) | Medicine for treating disc protrusion and bulge of lumbar vertebra and cervical vertebra | |
| CN103990093A (en) | Traditional Chinese medicine for treating obstructive emphysema caused by spleen-deficiency and phlegm-turbid stagnation | |
| CN104225536A (en) | Traditional Chinese medicine for treating stomach ulcer and duodenal ulcer | |
| CN104189859A (en) | Traditional Chinese medicine for treating lung cancer | |
| CN104324355A (en) | Traditional Chinese medicine composition for treating peripheral neuropathy caused by diabetes | |
| CN104474371A (en) | Traditional Chinese medicine for treating impotence | |
| CN104173986A (en) | Traditional Chinese medicine for treating heart failure | |
| CN104147551A (en) | Traditional Chinese medicine for treating polycystic ovarian syndrome | |
| CN103055298A (en) | Traditional Chinese medicine for treating rheumatoid cold arthralgia | |
| CN104147486A (en) | Traditional Chinese medicine for treating pediatric enuresis | |
| CN104189847A (en) | Traditional Chinese medicine for treating tuberculous exadative pleurisy | |
| CN104173834A (en) | Traditional Chinese medicine for treating meniere disease | |
| CN102526665B (en) | Chinese medicinal particles for clearing heat, allaying fever and treating cold | |
| CN104096203A (en) | Traditional Chinese medicine for treating miliaria sore toxin | |
| CN104069459A (en) | Traditional Chinese medicine composition for treating irritable bowel syndrome and preparation method thereof | |
| CN103316283B (en) | Traditional Chinese medicinal composition for treating chronic cholecystitis, and preparation method thereof | |
| CN104096184A (en) | Traditional Chinese medicine for treating hydrocele of tunica vaginalis of children | |
| CN104399042A (en) | Traditional Chinese medicine for treating intractable diaphragmatic muscle spasm and preparation method thereof | |
| CN104083749A (en) | Traditional Chinese medicine for treating polycystic ovarian syndrome | |
| CN100363044C (en) | Medicine for treating acne and its preparation method | |
| CN104225474A (en) | Traditional Chinese medicine for treating chronic lung abscess | |
| CN104189700A (en) | Traditional Chinese medicine for treating senile dementia | |
| CN104127632A (en) | Traditional Chinese medicine for curing lumbar spinal stenosis | |
| CN104173941A (en) | Traditional Chinese medicine for treating benign ovarian tumor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140820 |